Mimedx (MDXG) Cash from Operations (2011 - 2026)

Mimedx (MDXG) has 16 years of Cash from Operations data on file, last reported at 1879000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations fell 64.54% year-over-year to 1879000.0; the trailing twelve-month figure through Mar 2026 stood at 70583000.0 (up 6.22% YoY), and the FY2025 full-year result was 74003000.0, up 10.24% from the prior year.
• Cash from Operations fell to 1879000.0 in Q1 2026, from 24956000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 29329000.0 in Q3 2025 to a low of 10223000.0 in Q1 2022.
• A 5-year average of 9518411.76 and a median of 5978000.0 in 2024 frame the typical range for Cash from Operations.
• Across the five-year window, Cash from Operations plunged 287.93% in 2022 and jumped 1595.04% in 2024, its largest moves.
• Tracing MDXG's Cash from Operations over 5 years: stood at 4297000.0 in 2022, then slumped by 74.21% to 1108000.0 in 2023, then jumped by 1595.04% to 18781000.0 in 2024, then jumped by 32.88% to 24956000.0 in 2025, then tumbled by 92.47% to 1879000.0 in 2026.
• Business Quant data shows MDXG's Cash from Operations at 1879000.0 in Q1 2026, 24956000.0 in Q4 2025, and 29329000.0 in Q3 2025.